日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Radionuclide-stimulated dynamic therapy induces complementary immunogenic necroptosis and apoptosis cancer cell death pathways.

放射性核素刺激的动态疗法可诱导互补的免疫原性坏死性凋亡和凋亡性癌细胞死亡途径。

Egbulefu Christopher, Black Kvar, Su Xinming, Karmakar Partha, Habimana-Griffin LeMoyne, Sudlow Gail, Prior Julie, Onejeme Ezugo, Zheleznyak Alex, Xu Baogang, Xu Yalin, Esser Alison, Mixdorf Matthew, Moss Evan, Manion Brad, Hongsermeier Cody, Gamadia Nisha, Blasi Nicole, Stallings Luke, Alagbaoso Chidube, Reed Nathan, Gubin Matthew M, Lin Chieh-Yu, Schreiber Robert, Weilbaecher Katherine, Achilefu Samuel

Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer

利用无组织表观基因组学检测方法检测循环肿瘤DNA是早期三阴性乳腺癌的一种高度预后生物标志物

Ademuyiwa, Foluso O; Ma, Cynthia X; Weilbaecher, Katherine; Suresh, Rama; Peterson, Lindsay L; Bose, Ron; Bagegni, Nusayba; Rigden, Caron E; Frith, Ashley; Clifton, Katherine; Dustin, Derek; Cai, Mingyang; Xiong, Liyang; Chen, Sai; Davis, Andrew A

Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME

化疗与肿瘤外免疫微环境:额外时间

Phan, Tri Giang; Weilbaecher, Katherine N; Aft, Rebecca; Croucher, Peter I; Chaffer, Christine L

HTLV-1 infected T cells cause bone loss via small extracellular vesicles

HTLV-1 感染的 T 细胞通过小细胞外囊泡导致骨质流失

Nitin Kumar Pokhrel, Amanda R Panfil, Haniya Habib, Shamreethaa Seeniraj, Ancy Joseph, Daniel Rauch, Linda Cox, Robert Sprung, Petra Erdmann Gilmore, Qiang Zhang, Robert Reid Townsend, Lianbo Yu, Ayse Selen Yilmaz, Rajeev Aurora, William Park, Lee Ratner, Katherine N Weilbaecher, Deborah J Veis

Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells

对阿贝西利的耐药性与乳腺癌细胞转移潜能增加和溶酶体蛋白失调有关

Erin R Scheidemann, Diane M Demas, Chunyan Hou, Junfeng Ma, Wei He, Gaurav Sharma, Eric Schultz, Katherine N Weilbaecher, Ayesha N Shajahan-Haq

BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in Breast Cancer

BCAR4表达作为乳腺癌内分泌治疗耐药性的预测性生物标志物

Liao, Muheng; Webster, Jace; Coonrod, Emily M; Weilbaecher, Katherine N; Maher, Christopher A; White, Nicole M

p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy

p38MAPKα 基质重编程增强转移性乳腺癌对免疫疗法的敏感性

Douglas V Faget ,Xianmin Luo ,Matthew J Inkman ,Qihao Ren ,Xinming Su ,Kai Ding ,Michael R Waters ,Ganesh Kumar Raut ,Gaurav Pandey ,Paarth B Dodhiawala ,Renata Ramalho-Oliveira ,Jiayu Ye ,Thomas Cole ,Bhavna Murali ,Alexander Zheleznyak ,Monica Shokeen ,Kurt R Weiss ,Joseph B Monahan ,Carl J DeSelm ,Adrian V Lee ,Steffi Oesterreich ,Katherine N Weilbaecher ,Jin Zhang ,David G DeNardo ,Sheila A Stewart

Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer

基因组复杂性预测激素受体阳性(HR+)/HER2阴性转移性乳腺癌对内分泌治疗和CDK4/6抑制剂的耐药性

Davis, Andrew A; Luo, Jingqin; Zheng, Tiantian; Dai, Chao; Dong, Xiaoxi; Tan, Lu; Suresh, Rama; Ademuyiwa, Foluso O; Rigden, Caron; Rearden, Timothy P; Clifton, Katherine; Weilbaecher, Katherine; Frith, Ashley; Tandra, Pavan K; Summa, Tracy; Haas, Brittney; Thomas, Shana; Hernandez-Aya, Leonel F; Peterson, Lindsay L; Wang, Xiaohong; Luo, Shujun J; Zhou, Kemin; Du, Pan; Jia, Shidong; King, Bonnie L; Krishnamurthy, Jairam; Ma, Cynthia X

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)

palbociclib 加来曲唑加曲妥珠单抗作为临床 II 期和 III 期 ER+ HER2+ 乳腺癌新辅助治疗的 II 期研究 (PALTAN)

Ademuyiwa, Foluso O; Northfelt, Donald W; O'Connor, Tracey; Levine, Ellis; Luo, Jingqin; Tao, Yu; Hoog, Jeremy; Laury, Marie L; Summa, Tracy; Hammerschmidt, Trish; Guo, Zhanfang; Frith, Ashley; Weilbaecher, Katherine; Opyrchal, Mateusz; Aft, Rebecca; Clifton, Katherine; Suresh, Rama; Bagegni, Nusayba; Hagemann, Ian S; Iglesia, Michael D; Ma, Cynthia X

Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting

原发性和转移性乳腺癌中的转铁蛋白受体:评估表达和实验调节以改善分子靶向

Francesca Fontana, Alison K Esser, Christopher Egbulefu, Partha Karmakar, Xinming Su, John S Allen, Yalin Xu, Jennifer L Davis, Ariel Gabay, Jingyu Xiang, Kristin A Kwakwa, Brad Manion, Suzanne Bakewell, Shunqiang Li, Haeseong Park, Gregory M Lanza, Samuel Achilefu, Katherine N Weilbaecher